Top compounds associated with response to RP11-111K18.1


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.063 0.08
mRNA Bexarotene CTRPv2 pan-cancer AAC 0.064 0.08
mRNA CCT036477 CTRPv2 pan-cancer AAC -0.058 0.08
mRNA Obatoclax Mesylate CTRPv2 pan-cancer AAC 0.059 0.08
mRNA Docetaxel CTRPv2 pan-cancer AAC 0.085 0.08
mRNA OSI-027 CTRPv2 pan-cancer AAC 0.061 0.08
mRNA AZD-2281 CTRPv2 pan-cancer AAC -0.06 0.08
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.061 0.08
mRNA KU-60019 CTRPv2 pan-cancer AAC 0.06 0.08
mRNA tigecycline CTRPv2 pan-cancer AAC 0.085 0.08
Download CSV